500013-39-8 Usage
Uses
Used in Pharmaceutical Industry:
TERT-BUTYL 4-[3-(HYDROXYMETHYL)BENZYL]TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE is used as a pharmaceutical intermediate for the synthesis of various drugs and medicinal compounds. Its unique structure and functional groups may contribute to the development of new therapeutic agents with specific pharmacological properties.
Used in Organic Synthesis:
In the field of organic synthesis, TERT-BUTYL 4-[3-(HYDROXYMETHYL)BENZYL]TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE serves as a key building block or reactant in the preparation of complex organic molecules. Its versatility in undergoing various chemical reactions can facilitate the synthesis of target compounds with desired functionalities.
Used in Industrial Processes:
TERT-BUTYL 4-[3-(HYDROXYMETHYL)BENZYL]TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE may also find applications in various industrial processes, such as the production of specialty chemicals, materials, or coatings. Its unique structure and potential reactivity could be harnessed to create innovative products with specific properties or performance characteristics.
Check Digit Verification of cas no
The CAS Registry Mumber 500013-39-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,0,0,1 and 3 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 500013-39:
(8*5)+(7*0)+(6*0)+(5*0)+(4*1)+(3*3)+(2*3)+(1*9)=68
68 % 10 = 8
So 500013-39-8 is a valid CAS Registry Number.
InChI:InChI=1/C17H26N2O3/c1-17(2,3)22-16(21)19-9-7-18(8-10-19)12-14-5-4-6-15(11-14)13-20/h4-6,11,20H,7-10,12-13H2,1-3H3
500013-39-8Relevant academic research and scientific papers
benzamide derivatives as oxytocin agonists and vasopressin antagonists
-
Page 31, (2010/02/08)
Novel compounds according to general formula 1, wherein G1 is NR5R6 or a fused polycyclic group that are specific OT receptor agonists and/or Via receptor antagonists. Pharmaceutical compositions comprising such compounds are useful in the treatment of, inter alia, primary dysmenorrhoea.
